Clinical trial
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating…
NCT00003194 · Seattle Children's Hospital, Other · Terminated
Key facts
| NCT number | NCT00003194 |
|---|---|
| Title | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors |
| Official title | A Phase I Study of Thiotepa in Combination With Carboplatin and Topotecan With Peripheral Blood Progenitor Cell Support for the Treatment of Children With Recurrent or Refractory Solid Tumors. |
| Lead sponsor | Seattle Children's Hospital, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Childhood Solid Tumor, Protocol Specific |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, carboplatin, cyclophosphamide, etoposide, thiotepa, topotecan hydrochloride, peripheral blood stem cell transplantation |
| Enrollment | 24 |
| Start date | Jul 1, 1997 |
| Primary completion | Dec 19, 2002 |
| Completion | Dec 19, 2002 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 5, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: